Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Thyroid recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Thyroid (65 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Thyroid. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Thyroid recalls on record

none so far in 2026; 65 on record, newest first
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6150-2 D-1612-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5850-2 D-1611-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6050-2 D-1610-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5750-2 D-1609-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5650-2 D-1608-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5550-2 D-1607-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5450-4 D-1606-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3312-4 D-1605-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3310-4 D-1604-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3309-4 D-1603-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1602-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3307-4 D-1601-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1600-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-4 D-1599-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3299-4 D-1598-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3302-4 D-1597-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3300-4 D-1596-2020
Class II · Moderate risk

Thyroid Neutral Tabs 2 gr

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3308-02 D-1519-2020
Class II · Moderate risk

Thyroid 1 Gr tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3300-01 D-1518-2020
Class II · Moderate risk

Thyroid 1 Grain Tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3300-02 D-1517-2020
Class II · Moderate risk

Thyroid powder

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Alkano Chemicals, Inc NDC 7807-0170-11 D-0008-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-6580-43 D-0024-2019